市場調查報告書

生物醫藥品CMO(受託製造廠商)及CRO(研究受託機關)的全球市場:各原料、服務類型(受託製造、研究受託)、產品(生物製藥、生物相似藥) 2019年∼2025年

Biopharmaceutical CMO & CRO Market Size Analysis Report By Source, By Service Type (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2019 - 2025

出版商 Grand View Research, Inc. 商品編碼 544772
出版日期 內容資訊 英文 240 Pages
商品交期: 2-3個工作天內
價格
Back to Top
生物醫藥品CMO(受託製造廠商)及CRO(研究受託機關)的全球市場:各原料、服務類型(受託製造、研究受託)、產品(生物製藥、生物相似藥) 2019年∼2025年 Biopharmaceutical CMO & CRO Market Size Analysis Report By Source, By Service Type (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), And Segment Forecasts, 2019 - 2025
出版日期: 2019年05月08日內容資訊: 英文 240 Pages
簡介

全球生物醫藥品CMO(受託製造廠商)及CRO(研究受託機關)市場在2019年∼2025年間,預測將以7.7%的年複合成長率發展,到2025年成長到378億美元的規模。由於醫藥品開發商的生物學療法受到高度關注,促進該市場成長。

本報告提供全球生物醫藥品CMO(受託製造廠商)及CRO(研究受託機關)市場調查,市場概要,各原料、服務類型、產品、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查方法與範圍

  • 市場區隔和範圍
  • 市場定義
  • 資訊採購
  • 資訊分析
  • 市場形成和資料的視覺化
  • 資料檢驗與公開

第2章 摘要整理

  • 市場預測
  • 市場區隔
  • 市場洞察

第3章 市場變數,趨勢,展望

  • 市場預測
  • 滲透及成長預測的製圖
  • 產品平台分析:各階段
  • 原價結構分析
  • 用戶觀點分析
  • 治療成本分析
  • 終端用戶一覽:各服務、地區、國家
  • 技術概要
  • 法律規範
  • 市場動態
  • 市場分析工具
  • 生物醫藥品產業趨勢
  • 研究開發趨勢
  • 受託製造的顧客關係管理

第4章 生物醫藥品CMO&CRO市場:競爭分析

  • 參加企業的最近趨勢及影響分析
  • 公司區分
  • 業者情勢
  • 公開公司
  • 民營企業

第5章 生物醫藥品CMO&CRO市場:各原料

  • 定義和範圍
  • 市場佔有率分析:各原料(成果值、預測值)
  • 市場趨勢:各原料
  • 市場分析:各原料
  • 市場規模的變化與預測:各原料
    • 哺乳類原來原料
    • 非哺乳類原來原料
  • 生物醫藥品CMO&CRO市場:各產品

第6章 生物醫藥品CMO及CRO市場:各類服務

  • 定義和範圍
  • 市場佔有率分析:各類服務(成果值、預測值)
  • 市場趨勢:各類服務
  • 市場分析:各類服務
  • 市場規模的變化與預測:各類服務
    • 受託製造
    • 研究受託

第7章 生物醫藥品CMO及CRO市場:各產品

  • 定義和範圍
  • 市場佔有率分析:各產品(成果值、預測值)
  • 市場趨勢:各產品
  • 市場分析:各產品
  • 市場規模的變化與預測:各產品
    • 生技藥品
    • 生物相似藥

第8章生物醫藥品CMO及CRO市場:各地區

  • 市場佔有率分析:各地區(成果值、預測值)
  • 市場佔有率分析及主要企業:各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中南美
  • 中東、非洲

第9章 競爭形勢

  • 策略架構
  • 進入創辦企業的區分
  • 企業簡介
    • Boehringer Ingelheim GmbH
    • Lonza
    • Inno Biologics Sdn Bhd
    • Rentschler Biotechnologie SE
    • JRS PHARMA
    • BIOMEVA GmbH
    • ProBioGen AG
    • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    • Toyobo
    • Samsung BioLogics
    • Thermo Fisher Scientific Inc.
    • AGC Biologics
    • Binex Co., Ltd.
    • WuXi Biologics
    • AbbVie, Inc.
    • Charles River Laboratories International, Inc
    • ICON plc
    • Pharmaceutical Product Development, LLC
    • Laboratory Corporation of America Holdings
    • PAREXEL International Corporation
    • PRA Health Sciences

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-500-7

The global biopharmaceutical cmo & cro market size is expected to reach USD 37.8 billion by 2025, at a CAGR of 7.7%, according to a new report by Grand View Research, Inc. The market is significantly driven by the growing interest of conventional drug developers in biological therapeutics. At present, outsourcing has become a cost-saving strategy for small to medium sized biomanufacturers, as it helps eliminate the need for establishing expensive specialized facilities or hiring and training personnel.

The decline in R&D productivity and increased development costs has resulted in high pressure on biopharmaceutical manufacturers pertaining to short-term earnings and profit margins. This, in turn, has created lucrative opportunities for the Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to accelerate their business operations.

Robustness of venture capital investments is one of the important supportive factors that have created growth opportunities for CMOs. Venture capital funds are considered more reliable than public equity. Increasing availability of venture funds for life sciences is expected to further bolster the growth of CMOs. However, these CMOs and CROs are facing competition from in-house departments of pharmaceutical and biotechnology companies. Several big pharma companies like Novartis announced to keep their biomanufacturing process in-house.

Mammalian cell line-based bioproduction systems held the largest market share in terms of revenue in 2018. Factors responsible for this estimated share include growth in mammalian system titers and yields. CMOs are engaged in standardizing their mammalian systems, thereby driving the revenue growth of the segment. Contract research service is anticipated to be the fastest growing segment over the forecast period, attributed to increasing investment in research programs for development of novel therapeutics. The CMOs are majorly benefitted by the continuous market expansion of biologics.

Several biopharma companies from U.S. are considering Asian countries for development of pharma products. This is primarily due to the growing costs of R&D in their home country and the presence of low-cost production facilities and cheap labor in Asian countries. The key players are also involved in establishing mutually beneficial alliances with other emerging CMOs to scale up their production capabilities.

Further key findings from the report suggest:

Mammalian cell line-based bioproduction system accounted for the largest market share in terms of revenue in 2018

Plant-based expression systems are developed and explored as a cost-effective alternative for the production of large molecules

Contract manufacturing services accounted for the largest market share owing to the presence of wide range of services from cell line development to final packaging of the product

In recent times, biologics manufacturing is becoming more specialized, as a result, CMOs have become an integral part of the biologics production strategies of clients, leading to biologics gaining a large share of the biopharmaceutical CMO & CRO market

North America biopharmaceutical research industry is recognized as a leader in biopharmaceutical innovations, thereby resulting in the large share of this region

Some key CMOs are Lonza; Boehringer Ingelheim GmbH; Patheon; Samsung BioLogics; FUJIFILM Diosynth Biotechnologies U.S.A., Inc.

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Data Visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Biopharmaceutical CMO & CRO Market Outlook, 2014 - 2025
  • 2.2 Biopharmaceutical CMO & CRO Market : Segment Outlook, 2014 - 2025
  • 2.3 Biopharmaceutical CMO & CRO Market : Competitive Insights

Chapter 3 Biopharmaceutical CMO & CRO Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping, 2018
  • 3.3 Product Pipeline Analysis, by Stage
  • 3.4 Cost Structure Analysis
  • 3.5 User Perspective Analysis
    • 3.5.1. Consumer behavior analysis
    • 3.5.2. Market influencer analysis
  • 3.6 Procedure Cost Analysis/Breakdown
  • 3.7 List of Key End-users By Region, By Service Type, By Country
  • 3.8 Technology Overview
    • 3.9.3. Technology timeline
  • 3.9 Regulatory Framework
    • 3.9.1. Reimbursement framework
    • 3.9.2. Standards & compliances
  • 3.10 Biopharmaceutical CMO & CRO Market - Market Dynamics
    • 3.10.1 Market driver analysis
      • 3.10.1.1 Rising investment by CMOs for capacity expansion
      • 3.10.1.2 Commercial success of biopharmaceuticals and consequent increased demand for the biopharmaceuticals
      • 3.10.1.3 Robust biopharmaceuticals pipeline
      • 3.10.1.4 Cost and time saving benefits offered by contract services
    • 3.10.2 Market restraint analysis
      • 3.10.2.1 Limited outsourcing amongst well-stablished biopharmaceutical manufacturer
    • 3.10.3 Market challenges analysis
      • 3.10.3.1 Well established players are expanding their in-house biologic development procedures
  • 3.11 Biopharmaceutical CMO & CRO Market Analysis Tools
    • 3.11.1 Industry Analysis - Porter's
      • 3.11.1.1 Supplier Power: Substantial number of suppliers for bioprocessing equipment contributes to the low supplier power
      • 3.11.1.2 Buyer Power: Fragmaneted nature of biopharmaceutical industry led to moderate bargaining power of buyers
      • 3.11.1.3 Substitution Threat: High due to presence of large number big pharma companies
      • 3.11.1.4 New Entrants Threat: Presence of established players coupled with need of adequate capacity results in moderate threat of new entrants
      • 3.11.1.5 Competitive rivalry: High competitive rivalry amomg key players owing to significant number of merger & acquisitions and strategic alliances among biopharmaceutical developers
    • 3.11.2 PESTEL analysis
      • 3.11.2.1 Political landscape
      • 3.11.2.2 Environmental landscape
      • 3.11.2.3 Social landscape
      • 3.11.2.4 Technology landscape
      • 3.11.2.5 Legal landscape
    • 3.11.3 Major deals & strategic alliances analysis
      • 3.11.3.1 Joint ventures
      • 3.11.3.2 Mergers & acquisitions
      • 3.11.3.3 Licensing & partnership
      • 3.11.3.4 Technology collaborations
      • 3.11.3.5 Strategic divestments
    • 3.11.4 Market entry strategies
    • 3.11.5 Case studies
  • 3.12 Trends in Biopharmaceutical Industry
  • 3.13 R&D Landscape of Biopharmaceuticals
  • 3.14 Customer Relationship Management in Contract Manufacturing
    • 3.14.1 Selection process of CMO
    • 3.14.2 Operations and quality oversight of CMOs

Chapter 4 Biopharmaceutical CMO & CRO Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Company/Competition Categorization
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2018
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis
    • 4.4.2 Company market share/ranking by region
    • 4.4.3 Competitive dashboard analysis
    • 4.4.4 Market differentiators
    • 4.4.5 Synergy analysis: Major deals & strategic alliances
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
    • 4.5.2 Funding outlook
    • 4.5.3 Regional network map
    • 4.5.4 Company market position analysis
    • 4.5.5 Supplier Ranking

Chapter 5 Biopharmaceuticals CMO & CRO Market: Source Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Source Market Share Analysis, 2018 & 2025
  • 5.3 Biopharmaceuticals CMO & CRO Market: Source Movement Analysis, 2018 & 2025
  • 5.4 Global Biopharmaceuticals CMO & CRO Market, by Source, 2014 to 2025
  • 5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
    • 5.5.1 Mammalian source
      • 5.5.1.1 Global mammalian source market, 2014 - 2025 (USD Million)
    • 5.5.2 Non-mammalian Source
      • 5.5.2.1 Global non-mammalian source market, 2014 - 2025 (USD
  • 5.6 Biopharmaceuticals CMO & CRO Source Market, by Product, 2014 to 2025

Chapter 6 Biopharmaceuticals CMO & CRO Market: Service Type Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Service Type Market Share Analysis, 2018 & 2025
  • 6.3 Biopharmaceuticals CMO & CRO Market: Service Type Movement Analysis, 2018 & 2025
  • 6.4. Global Biopharmaceuticals CMO & CRO Market, by Service Type, 2014 to 2025
  • 6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
    • 6.5.1 Contract manufacturing, by service
      • 6.5.1.1 Global contract manufacturing market, 2014 - 2025 (USD Million)
      • 6.5.1.2 Process development
      • 6.5.1.2.1 Global process development market, 2014 - 2025 (USD Million)
      • 6.5.1.2.2 Downstream processing
      • 6.5.1.2.2.1 Global downstream processing market, 2014 - 2025 (USD Million)
      • 6.5.1.2.3 Upstream processing
      • 6.5.1.2.3.1 Global upstream processing market, 2014 - 2025 (USD Million)
      • 6.5.1.3 Process development
      • 6.5.1.3.1 Global process development market, 2014 - 2025 (USD Million)
      • 6.5.1.4 Fill & finish operations
      • 6.5.1.4.1 Global fill & finish operations market, 2014 - 2025 (USD Million)
      • 6.5.1.5 Analytical & QC testing
      • 6.5.1.5.1 Global analytical & QC testing market, 2014 - 2025 (USD Million)
      • 6.5.1.6 Packaging
      • 6.5.1.6.1 Global contract packaging market, 2014 - 2025 (USD Million)
    • 6.5.2 Contract research
      • 6.5.2.1 Global contract research market, 2014 - 2025 (USD Million)
      • 6.5.2.2 Oncology
      • 6.5.1.2.1 Global oncology market, 2014 - 2025 (USD Million)
      • 6.5.2.3 Inflammation & immunology
      • 6.5.2.3.1 Global inflammation & immunology market, 2014 - 2025 (USD Million)
      • 6.5.2.4 Cardiology
      • 6.5.2.4.1 Global cardiology market, 2014 - 2025 (USD Million)
      • 6.5.2.5 Neuroscience
      • 6.5.1.5.1 Global neuroscience market, 2014 - 2025 (USD Million)
      • 6.5.2.6 Others
      • 6.5.1.6.1 Global other CRO services market, 2014 - 2025 (USD Million)

Chapter 7 Biopharmaceuticals CMO & CRO Market: Product Estimates & Trend Analysis

  • 7.1. Definitions & Scope
  • 7.2. Product Market Share Analysis, 2018 & 2025
  • 7.3 Biopharmaceuticals CMO & CRO Market: Product Movement Analysis, 2018 & 2025
  • 7.4. Global Biopharmaceuticals CMO & CRO Market, by Product, 2014 to 2025
  • 7.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
    • 7.5.1 Biologics
      • 7.5.1.1 Global biologics market, 2014 - 2025 (USD Million)
      • 7.5.1.2 Monoclonal antibodies
      • 7.5.1.2.1 Global monoclonal antibodies market, 2014 - 2025 (USD Million)
      • 7.5.1.3 Recombinant proteins
      • 7.5.1.3.1 Global recombinant proteins market, 2014 - 2025 (USD Million)
      • 7.5.1.4 Vaccines
      • 7.5.1.4.1 Global vaccines market, 2014 - 2025 (USD Million)
      • 7.5.1.5 Antisense, RNAi, & molecular therapy
      • 7.5.1.5.1 Global antisense, RNAi, & molecular therapy market, 2014 - 2025 (USD Million)
      • 7.5.1.6 Others
      • 7.5.1.7.1 Global other product market, 2014 - 2025 (USD Million)
    • 7.5.2 Biosimilars
      • 7.5.2.1 Global biosimilars market, 2014 - 2025 (USD Million)

Chapter 8 Biopharmaceuticals CMO & CRO Market: Regional Estimates & Trend Analysis, by Source, Service Type, & Product

  • 8.1 Biopharmaceuticals CMO & CRO Market Share by Region, 2018 & 2025
  • 8.2 Regional Market Share and Leading Players, 2018
    • 8.2.1 North America
    • 8.2.2 Europe
    • 8.2.3 Asia Pacific
    • 8.2.4 Latin America
    • 8.2.5 Middle East & Africa
  • 8.3 North America
    • 8.3.1 North America biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.3.2.2 U.S. biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.3.2.3 U.S. biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.3.3.2 Canada biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.3.3.3 Canada biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
    • 8.4.2 Germany
      • 8.4.2.1 Germany biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.4.2.2 Germany biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.4.2.3 Germany biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)
    • 8.4.3 France
      • 8.4.3.1 France biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.4.3.2 France biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.4.3.3 France biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
    • 8.5.2 China
      • 8.5.2.1 China biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.5.2.2 China biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.5.2.3 China biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)
    • 8.5.3 India
      • 8.5.3.1 India biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.5.3.2 India biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.5.3.3 India biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Brazil biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.6.2.2 Brazil biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.6.2.3 Brazil biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)
  • 8.7 Middle East & Africa (MEA)
    • 8.7.1 Middle East & Africa biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa biopharmaceuticals CMO & CRO market, by source, 2014 - 2025 (USD Million)
      • 8.7.2.2 South Africa biopharmaceuticals CMO & CRO market, by service type, 2014 - 2025 (USD Million)
      • 8.7.2.3 South Africa biopharmaceuticals CMO & CRO market, by product, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.1.1 Boehringer Ingelheim GmbH
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Product benchmarking
      • 9.1.1.4 Strategic initiatives
    • 9.1.2 Lonza
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial performance
      • 9.1.2.3 Product benchmarking
      • 9.1.2.4 Strategic initiatives
    • 9.1.3 Inno Biologics Sdn Bhd
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Product benchmarking
      • 9.1.3.4 Strategic initiatives
    • 9.1.4 Rentschler Biotechnologie SE
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 JRS PHARMA
      • 9.1.5.1 Company overview
      • 9.1.5.1.1 CELONIC AG
      • 9.1.5.2 Financial performance
      • 9.1.5.2.1 Financial performance
      • 9.1.5.3 Product benchmarking
      • 9.1.5.4 Strategic initiatives
    • 9.1.6 BIOMEVA GmbH
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial performance
      • 9.1.6.3 Product benchmarking
      • 9.1.6.4 Strategic initiatives
    • 9.1.7 ProBioGen AG
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial performance
      • 9.1.7.3 Product benchmarking
      • 9.1.7.4 Strategic initiatives
    • 9.3.8 FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
      • 9.3.8.1 Company overview
      • 9.3.8.2 Financial performance
      • 9.3.8.3 Product benchmarking
      • 9.3.8.4 Strategic initiatives
    • 9.3.9 TOYOBO CO., LTD.
      • 9.3.9.1 Company overview
      • 9.3.9.2 Financial performance
      • 9.3.9.3 Product benchmarking
      • 9.3.9.4 Strategic initiatives
    • 9.3.10 Samsung BioLogics
      • 9.3.10.1 Company overview
      • 9.3.10.2 Financial performance
      • 9.3.10.3 Product benchmarking
      • 9.3.10.4 Strategic initiatives
    • 9.3.11 Thermo Fisher Scientific Inc.(Patheon)
      • 9.3.11.1 Company overview
      • 9.3.11.1.1 DPx
      • 9.3.11.2 Financial performance
      • 9.3.11.3 Product benchmarking
      • 9.3.11.4 Strategic initiatives
    • 9.3.12 AGC Biologics (CMC Biologics)
      • 9.3.12.1 Company overview
      • 9.3.12.2 Financial performance
      • 9.3.12.3 Product benchmarking
      • 9.3.12.4 Strategic initiatives
    • 9.3.13 Binex Co., Ltd.
      • 9.3.13.1 Company overview
      • 9.3.13.2 Financial performance
      • 9.3.13.3 Product benchmarking
      • 9.3.13.4 Strategic initiatives
    • 9.3.14 WuXi Biologics
      • 9.3.14.1 Company overview
      • 9.3.14.2 Financial performance
      • 9.3.14.3 Product benchmarking
      • 9.3.14.4 Strategic initiatives
    • 9.3.15 AbbVie, Inc.
      • 9.3.15.1 Company overview
      • 9.3.15.2 Financial performance
      • 9.3.15.3 Product benchmarking
      • 9.3.15.4 Strategic initiatives
    • 9.3.16 Charles River Laboratories International, Inc
      • 9.3.16.1 Company overview
      • 9.3.16.2 Financial performance
      • 9.3.16.3 Product benchmarking
      • 9.3.16.4 Strategic initiatives
    • 9.3.17 ICON plc
      • 9.3.17.1 Company overview
      • 9.3.17.2 Financial performance
      • 9.3.17.3 Product benchmarking
      • 9.3.17.4 Strategic initiatives
    • 9.3.18 Pharmaceutical Product Development, LLC
      • 9.3.18.1 Company overview
      • 9.3.18.2 Financial performance
      • 9.3.18.3 Product benchmarking
      • 9.3.18.4 Strategic initiatives
    • 9.3.19 Laboratory Corporation of America Holdings
      • 9.3.19.1 Company overview
      • 9.3.19.2 Financial performance
      • 9.3.19.3 Product benchmarking
      • 9.3.19.4 Strategic initiatives
    • 9.3.20 PAREXEL International Corporation
      • 9.3.20.1 Company overview
      • 9.3.20.2 Financial performance
      • 9.3.20.3 Product benchmarking
      • 9.3.20.4 Strategic initiatives
    • 9.3.21 PRA Health Sciences
      • 9.3.21.1 Company overview
      • 9.3.21.2 Financial performance
      • 9.3.21.3 Product benchmarking
      • 9.3.21.4 Strategic initiatives
  • 9.4 List of Companies

List of Tables

  • TABLE 1 2018 pipeline of biologics
  • TABLE 2 Annual outsourcing budget in 2012
  • TABLE 3 Some commercially available biopharmaceuticals and biologics produced using mammalian cell lines
  • TABLE 4 Some commercially available biopharmaceuticals and biologics produced using mammalian cell lines
  • TABLE 5 Some biopharmaceuticals produced using S. cerevisiae
  • TABLE 6 Some commercially available biopharmaceuticals and biologics produced using microbial cell lines
  • TABLE 7 Some commercially available monoclonal antibody products
  • TABLE 8 Number of MAbs products by indication area, 2015
  • TABLE 9 Time and budget requirement for different stages of vaccine development
  • TABLE 10 North America biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 11 North America biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 12 North America biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 13 North America biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 14 North America biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 15 North America biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 16 North America biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 17 North America biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 18 North America biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 19 North America biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 20 North America biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 21 North America biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 22 North America biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 23 North America biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 24 U.S. biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 25 U.S. biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 26 U.S. biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 27 U.S. biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 28 U.S. biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 29 U.S. biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 30 U.S. biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 31 U.S. biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 32 U.S. biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 33 U.S. biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 34 U.S. biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 35 U.S. biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 36 U.S. biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 37 U.S. biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 38 Canada biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 39 Canada biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 40 Canada biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 41 Canada biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 42 Canada biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 43 Canada biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 44 Canada biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 45 Canada biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 46 Canada biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 47 Canada biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 48 Canada biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 49 Canada biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 50 Canada biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 51 Canada biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 52 Europe biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 53 Europe biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 54 Europe biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 55 Europe biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 56 Europe biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 58 Europe biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 59 Europe biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 60 Europe biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 61 Europe biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 62 Europe biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 63 Europe biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 64 Europe biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 65 Europe biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 66 Europe biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 67 Germany biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 68 Germany biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 69 Germany biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 70 Germany biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 71 Germany biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 72 Germany biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 73 Germany biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 74 Germany biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 75 Germany biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 76 Germany biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 77 Germany biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 78 Germany biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 79 Germany biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 80 Germany biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 81 France biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 82 France biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 83 France biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 84 France biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 85 France biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 86 France biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 87 France biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 88 France biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 89 France biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 90 France biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 91 France biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 92 France biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 93 France biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 94 France biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 95 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 96 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 97 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 98 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 99 Asia Pacific biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 100 Asia Pacific biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 101 Asia Pacific biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 102 Asia Pacific biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 103 Asia Pacific biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 104 Asia Pacific biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 105 Asia Pacific biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 106 Asia Pacific biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 107 Asia Pacific biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 108 Asia Pacific biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 109 China biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 110 China biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 111 China biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 112 China biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 113 China biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 114 China biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 115 China biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 116 China biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 117 China biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 118 China biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 119 China biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 120 China biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 121 China biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 122 China biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 123 India biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 124 India biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 125 India biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 126 India biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 127 India biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 128 India biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 129 India biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 130 India biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 131 India biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 132 India biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 133 India biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 134 India biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 135 India biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 136 India biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 137 Latin America biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 138 Latin America biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 139 Latin America biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 140 Latin America biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 141 Latin America biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 142 Latin America biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 143 Latin America biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 144 Latin America biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 145 Latin America biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 146 Latin America biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 147 Latin America biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 148 Latin America biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 149 Latin America biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 150 Latin America biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 151 Brazil biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 152 Brazil biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 153 Brazil biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 154 Brazil biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 155 Brazil biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 156 Brazil biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 157 Brazil biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 158 Brazil biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 159 Brazil biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 160 Brazil biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 161 Brazil biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 162 Brazil biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 163 Brazil biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 164 Brazil biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 165 MEA biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 166 MEA biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 167 MEA biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 168 MEA biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 169 MEA biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 170 MEA biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 171 MEA biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 172 MEA biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 173 MEA biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 174 MEA biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 175 MEA biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 176 MEA biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 177 MEA biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 178 MEA biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 179 South Africa biopharmaceuticals CMO & CRO market estimates, by source, 2014 - 2018 (USD Million)
  • TABLE 180 South Africa biopharmaceuticals CMO & CRO market forecasts, by source, 2019 - 2025 (USD Million)
  • TABLE 181 South Africa biopharmaceuticals CMO & CRO market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 182 South Africa biopharmaceuticals CMO & CRO market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 183 South Africa biopharmaceuticals contract manufacturing market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 184 South Africa biopharmaceuticals contract manufacturing market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 185 South Africa biopharmaceuticals process development market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 186 South Africa biopharmaceuticals process development market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 187 South Africa biopharmaceuticals contract research market estimates, by service type, 2014 - 2018 (USD Million)
  • TABLE 188 South Africa biopharmaceuticals contract research market forecasts, by service type, 2019 - 2025 (USD Million)
  • TABLE 189 South Africa biopharmaceuticals CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 190 South Africa biopharmaceuticals CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)
  • TABLE 191 South Africa biologics CMO & CRO market estimates, by product, 2014 - 2018 (USD Million)
  • TABLE 192 South Africa biologics CMO & CRO market forecasts, by product, 2019 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modelling for market share assessment
  • FIG. 7 Market segmentation & scope
  • FIG. 8 Biopharmaceutical CMO & CRO market outlook, 2014 - 2025
  • FIG. 9 Market trends & outlook
  • FIG. 10 Penetration & growth prospect mapping for contract manufacturing service, 2018
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Cumulative success rate comparison of biologics with small molecules over time
  • FIG. 13 Number of biologics investigational new drugs, 2005 - 2015
  • FIG. 14 Number of Reference Products by U.S. Biosimilars Launchable Dates
  • FIG. 15 Market restraint relevance analysis (Current & future impact)
  • FIG. 16 Risk associated with outsourcing services
  • FIG. 17 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 19 Porter's Five Forces Analysis
  • FIG. 20 Company market share analysis
  • FIG. 21 Strategy framework
  • FIG. 22 Participant categorization
  • FIG. 23 CMO selection process
  • FIG. 24 Trends in biopharmaceutical industry
  • FIG. 25 R&D process of biopharmaceutical development
  • FIG. 26 Development phases where outsourcing partners are engaged
  • FIG. 27 Global Biopharmaceuticals CMO & CRO market: Source outlook key takeaways
  • FIG. 28 Global Biopharmaceuticals CMO & CRO market: Source movement analysis
  • FIG. 29 Global mammalian source market, 2014 - 2025 (USD Million)
  • FIG. 30 Global mammalian source market, 2014 - 2025 (USD Million)
  • FIG. 31 Global Biopharmaceuticals CMO & CRO market: Service type outlook key takeaways
  • FIG. 32 Global Biopharmaceuticals CMO & CRO market: Service movement analysis
  • FIG. 33 Global contract manufacturing market, 2014 - 2025 (USD Million)
  • FIG. 34 Percentage of biomanufacturers outsourcing some activity of upstream and downstream processing, 2011-2016
  • FIG. 35 Global process development market, 2014 - 2025 (USD Million)
  • FIG. 36 Global downstream processing market, 2014 - 2025 (USD Million)
  • FIG. 37 Global upstream processing market, 2014 - 2025 (USD Million)
  • FIG. 38 Global fill & finish operations market, 2014 - 2025 (USD Million)
  • FIG. 39 Global analytical & QC testing market, 2014 - 2025 (USD Million)
  • FIG. 40 Global contract packaging market, 2014 - 2025 (USD Million)
  • FIG. 41 Breakdown of the general CRO industry by type of service
  • FIG. 42 Initial attributes that play key role into CRO engagement
  • FIG. 43 Post-engagement attributes that play key role into CRO engagement
  • FIG. 44 Global contract research market, 2014 - 2025 (USD Million)
  • FIG. 45 Global oncology market, 2014 - 2025 (USD Million)
  • FIG. 46 Global inflammation & immunology market, 2014 - 2025 (USD Million)
  • FIG. 47 Global cardiology market, 2014 - 2025 (USD Million)
  • FIG. 48 Global neuroscience market, 2014 - 2025 (USD Million)
  • FIG. 49 Global other CRO services market, 2014 - 2025 (USD Million)
  • FIG. 50 Global Biopharmaceuticals CMO & CRO market: Product outlook key takeaways
  • FIG. 51 Global Biopharmaceuticals CMO & CRO market: Product movement analysis
  • FIG. 52 Global biologics market, 2014 - 2025 (USD Million)
  • FIG. 53 Year wise annual approvals for MAbs products which are currently marketed in U.S./EU
  • FIG. 54 Share of MAbs-related R&D programs at different pipeline phases, 2015
  • FIG. 55 Global monoclonal antibodies market, 2014 - 2025 (USD Million)
  • FIG. 56 Comparison of R&D biotech pipeline expansion for recombinant products
  • FIG. 57 Global recombinant proteins market, 2014 - 2025 (USD Million)
  • FIG. 58 Global vaccines market, 2014 - 2025 (USD Million)
  • FIG. 59 Global antisense, RNAi, & molecular therapy market, 2014 - 2025 (USD Million)
  • FIG. 60 Global other product market, 2014 - 2025 (USD Million)
  • FIG. 61 Global biosimilars market, 2014 - 2025 (USD Million)
  • FIG. 62 Regional market place: Key takeaway
  • FIG. 63 Comparison of biopharmaceutical manufacturing facilities region and country wise
  • FIG. 64 Biopharmaceuticals CMO & CRO regional outlook, 2018 & 2025
  • FIG. 65 North America Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 66 Number of U.S. pharmaceutical outsourcing M&A transactions
  • FIG. 67 Biopharmaceuticals goods export growth comparison between 2011 and 2014
  • FIG. 68 U.S. biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 69 Pros and cons of Canadian pharmaceutical & biopharmaceutical industry
  • FIG. 70 Canada Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 71 Europe Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 72 Revenue growth of Germany pharmaceutical industry
  • FIG. 73 Germany biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 74 France biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 75 Factors supporting contract manufacturing/research in Asian countries
  • FIG. 76 Asia Pacific biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 77 China Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 78 India Biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 79 Latin America biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 80 Brazil biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 81 Middle East & Africa biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 82 South Africa biopharmaceuticals CMO & CRO market, 2014 - 2025 (USD Million)
  • FIG. 83 Strategy framework
  • FIG. 84 Participant categorization
  • FIG. 85 List of companies
Back to Top